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In the research domain framework (RDoC), dysfunctional reward expectation has been
proposed to be a cross-diagnostic domain in psychiatry, which may contribute to
symptoms common to various neuropsychiatric conditions, such as anhedonia or
apathy/avolition. We used a modified version of the Monetary Incentive Delay (MID)
paradigm to obtain functional MRI images from 22 patients with schizophrenia, 24 with
depression and 21 controls. Anhedonia and other symptoms of depression, and overall
positive and negative symptomatology were also measured. We hypothesized that the
two clinical groups would have a reduced activity in the ventral striatum when anticipating
reward (compared to anticipation of a neutral outcome) and that striatal activation would
correlate with clinical measures of motivational problems and anhedonia. Results were
consistent with the first hypothesis: two clusters in both the left and right ventral striatum
were found to differ between the groups in reward anticipation. Post-hoc analysis showed
that this was due to higher activation in the controls compared to the schizophrenia and
the depression groups in the right ventral striatum, with activation differences between
depression and controls also seen in the left ventral striatum. No differences were
found between the two patient groups, and there were no areas of abnormal cortical
activation in either group that survived correction for multiple comparisons. Reduced
ventral striatal activity was related to greater anhedonia and overall depressive symptoms
in the schizophrenia group, but not in the participants with depression. Findings are
discussed in relation to previous literature but overall are supporting evidence of reward
system dysfunction across the neuropsychiatric continuum, even if the specific clinical
relevance is still not fully understood. We also discuss how the RDoC approach may help
to solve some of the replication problems in psychiatric fMRI research.
Keywords: reward system, ventral striatum, monetary incentive delay, depressive symptoms, research domain
framework
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Introduction
Current psychiatric diagnostic manuals divide psychopathology
into separate diagnostic categories based in the co-occurrence
of signs and symptoms rather than on the basis of underlying
physiology. However, within each of these categories there is
great heterogeneity in the type and severity of symptoms and,
similarly, it is common to have overlap in symptoms between
the diﬀerent diagnoses (Lilienfeld, 2014). Recently the Research
Domain Criteria (RDoC) framework has been proposed as an
alternative framework in order to advance the understanding
of mental disorders (Insel et al., 2010). The speciﬁc aim of the
RDoC project is to increase research that validates new cross-
diagnostic dimensions and biological and behavioral measures
to carry out better classiﬁcations of mental problems. To achieve
this improved classiﬁcation, the RDoC group has proposed a set
of ﬁve domains or functional systems that are typically aﬀected in
psychopathology, and seven units of analysis at which these ﬁve
constructs can be studied, thus creating a 2-dimensional matrix
that can guide research. Additionally, this matrix also includes a
further column of “paradigms,” that is, tools that can be used to
measure abnormalities in the domains (Cuthbert, 2014a).
Schizophrenia patients, as deﬁned in current diagnostic
manuals, typically suﬀer from symptoms of psychosis (delusions,
hallucinations, and disordered behavior, thought, and speech),
whereas depression patients are diagnosed on the basis of low
mood, anhedonia, and accompanying physical symptoms such
as reduced energy. However, psychotic symptoms can appear
in the course of a major depressive episode and low mood,
blunted aﬀect, alogia, or anhedonia are also characteristic of
schizophrenia (Bedwell et al., 2014). Moreover, the boundary
between depression and schizophrenia is frequently unclear, and
the diagnosis of schizoaﬀective disorder is often used in cases in
which a patient has features of mood disorder and schizophrenia.
Additionally, the existence of mild symptoms of psychosis in
young people, previously thought to be confer a high risk for
schizophrenia, has been shown to be a more general risk factor
for diﬀerent psychiatric disorders including depression (Murray
and Jones, 2012; Hui et al., 2013).
At the cognitive-behavioral construct level, disrupted reward
processing has been implicated in both schizophrenia and
depression. Moreover, it has been suggested that whereas reward
receipt may only be subtly aﬀected in both disorders (Cohen and
Minor, 2010; Arrondo et al., 2015), the anticipation of reward
(Juckel et al., 2006b; Sherdell et al., 2012) and its motivational
aspects (e.g., the eﬀort that a subject is willing to make to get it)
(Treadway et al., 2012; Barch et al., 2014; Gard et al., 2014) may
be markedly dysfunctional in schizophrenia and in depression
(for in-depth reviews of the issue see Barch and Dowd, 2010;
Kring and Caponigro, 2010; Treadway and Zald, 2011; Der-
Avakian and Markou, 2012; Argyropoulos and Nutt, 2013; Kring
and Barch, 2014; Whitton et al., 2015). Abnormalities in reward
prediction error signaling in the striatum in schizophrenia
are also a well-known ﬁnding that could be involved in the
pathogenesis of psychotic symptoms (Fletcher and Frith, 2009;
Ziauddeen and Murray, 2010). Similar changes have also been
found in depression (Kumar et al., 2008), and indeed when
participants in both patient groups were studied within the
same prediction error learning paradigm researchers found brain
activation diﬀerences between controls and the two groups of
patients (Gradin et al., 2011).
Hence, consistent with the RDoC proposal, there appears to
be dimensional continuity between schizophrenia and depression
with respect to at least some aspects of reward processing.
According to the RDoC matrix some of the stated similarities
would ﬁt in the Positive Valence systems domain, which
is deﬁned as involving “Systems primarily responsible for
responses to positive motivational situations or contexts, such
as reward seeking, consummatory behavior, and reward/habit
learning,” and speciﬁcally the Expectancy/Reward Prediction
Error component within the Approach Motivation subsystem.
The ventral striatum/nucleus accumbens is considered a key
area involved in the processing of reward anticipation, and the
main neurotransmitter thought to be involved in predicting
rewards and learning from them is dopamine. The Monetary
Incentive Delay task (MID) is a paradigm that it is well-known
to elicit strong striatal activations related to the expectation
and salience of rewards (Knutson et al., 2001). It has been
widely used both in the healthy population and in patients with
neuropsychiatric symptoms, with several results pointing toward
both schizophrenia and depression patients having a decreased
activity in the striatum when anticipating rewards (Juckel et al.,
2006a,b; Nielsen et al., 2012; Stoy et al., 2012). Moreover,
reanalyzing data from a set of studies, Hägele and colleagues
showed that depression, schizophrenia and alcohol disorders
were all associated with reduced activity in the right ventral
striatum with this eﬀect correlated with depressive symptoms
as measured by the Beck Depression Inventory (Hägele et al.,
2015). However, given that patient groups were not matched
to each other or to controls in age and gender in the study
by Hägele and colleagues we sought to replicate and extend it
using a speciﬁcally-designed study with matched groups; we also
wished to relate neural responses to additional key symptoms, as
previous work has indicated that ventral striatum (de)activation
could also relate to other symptoms such as anhedonia (Simon
et al., 2010; Stoy et al., 2012) and more generally, to positive
(Nielsen et al., 2012), and negative (Juckel et al., 2006a; Waltz
et al., 2009) symptoms.
In brief, we compared patients with depression and
schizophrenia to healthy controls in a Monetary Incentive
Delay task. The aim was to further understand how perturbation
of the anticipation of reward relates to anhedonia, depression,
and overall positive and negative symptoms. Consistent with
the results of Hägele and colleagues, we hypothesized that
the two clinical groups would have a reduced activity in the
ventral striatum when anticipating reward and that the striatal
activation would correlate with clinical measures (in a direction
such that patients with the least activation would have the more
pronounced psychopathology).
Materials and Methods
Participants
Sixty seven participants were recruited for the study, of whom
22 had a diagnosis of schizophrenia, 24 a diagnosis of major
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depressive disorder and 21 were healthy volunteers. DSM-IV
criteria were used for group classiﬁcation. Inclusion criteria were
to be aged between 18 and 65 and speak English proﬁciently.
Exclusion criteria were any contraindication for entering a MRI
scan and history of neurological disorder, physical illness, and
alcohol or drug dependence. Participants from both clinical
groups had subjective symptoms of anhedonia. Demographic
and clinical details of participants are provided in Table 1.
Patients with schizophrenia were recruited through psychiatric
community services of the Cambridgeshire and Peterborough
NHS Foundation Trust. Patients with depression were recruited
through psychiatric and psychological community services of
the Cambridgeshire and Peterborough NHS Foundation Trust,
and through public advertisement. Diagnoses for patients from
psychiatric services of the Cambridgeshire and Peterborough
NHS Foundation Trust and suitability for the study were
conﬁrmed by the review of all available clinical and anamnestic
information by each individual’s psychiatrist (an experienced
psychiatrist with several years of postgraduate experience
who had passed the membership examination of the Royal
College of Psychiatrists). Diagnoses for patients recruited from
psychology services or advertisement were conﬁrmed by a
psychiatric interview including PANSS (Kay et al., 1987) and
assessment with the Mini-International Psychiatric Inventory
(Sheehan et al., 1998) the interview was conducted either
by an experienced research psychiatrist with several years
of postgraduate experience who had passed the membership
examination of the Royal College of Psychiatrists or by a
registered clinical psychologist with several years postgraduate
experience.
Thirteen of the depressed participants were taking
antidepressant medication: citalopram 30–60mg daily,
mirtazapine 30–45 mg, and venlafaxine 75–225 mg. All
patients with schizophrenia were taking atypical antipsychotic
medication (speciﬁcally clozapine, aripiprazole, risperidone,
quetiapine, or olanzapine); two patients were taking a
combination of typical and atypical medication. The mean
chlorpromazine equivalent dose was 401.24 (sd 91.43) mg/day
(Kroken et al., 2009). Eight patients with schizophrenia were
additionally taking antidepressant medication: citalopram
20–40mg, ﬂuoxetine 20mg, mirtazapine 45mg, venlafaxine
150–225mg.
The study was conducted at University of Cambridge
(Wolfson Brain Imaging Centre and Department of Psychiatry).
All participants were evaluated using the following clinical scales:
Brief Psychiatric Rating Scale (BPRS, Overall and Gorham,
1962); Positive and Negative Syndrome Scale (PANSS, Kay
et al., 1987); Scale for the Assessment of Negative Symptoms
Beck Depression Inventory, (SANS, BDI, Beck et al., 1996);
Snaith–Hamilton Pleasure Scale (SHAPS, Snaith et al., 1995);
and the Temporal Experience of Pleasure scale–TEPS, (Gard
et al., 2006). Scales were selected to measure constructs
with a possible striatal neural substrate and also according
to previous ﬁndings of signiﬁcant correlations with ventral
striatum activity during the MID. The Cattell Culture Fair
Intelligence Test (CFIT) was used to measure IQ (Cattell et al.,
1973).
The study was approved by the Cambridgeshire 3 National
Health Service research ethics committee. Written informed
consent was obtained from all participants prior to participation.
fMRI Paradigm
The fMRI paradigm was a variation of the Monetary Incentive
Delay (MID) task (Figure 1). It used an event-related design in
which stimuli served as cues signaling the subsequent outcome.
Overall, there were 60 trials in the experiment, which was
conducted in a single scanning session. There were two types of
cues (after Kirsch et al., 2003): reward cue (an arrow pointing
upwards; 30 events) or neutral (a horizontal bar with arrows in
both extremes; 30 events), and the participants were instructed
to press a button in a rapid manner when requested, after the
cues disappeared but before the outcome was known. After a 1–
4 s random interval showing a ﬁxation cross, the image of a coin
indicated the amount of reward (£1 in 70% of the events and 1
penny in 30%; 21 and 9 events) in the case of the win cue, whereas
a yellow or orange circle (70 and 30% of events, respectively;
21 and 9 events) were shown after the neutral cue. Hence,
despite our instruction to the participants (which was designed
to help engagement with the task), rewards did not depend
on the subject’s performance while pressing the button. This
alteration from the original MID task was intended to reduce
the confounds of motor preparation and task-induced anxiety
which have been proposed as possible reasons for the previously
inconsistent results in depression using the MID (Treadway and
Zald, 2011). The inter-trial interval, in which a black screen was
shown, lasted between 2 and 6 s. Reward and neutral cues, as well
as ensuing outcomes were pseudo-randomly presented. Thus,
the design was optimized to detect diﬀerences between the two
anticipation conditions. Behavioral information obtained from
the task included reaction time and responses. Data on response
times was lost for 8 participants due to programming problems
that did not aﬀect acquisition of other data.
MRI Acquisition and Preprocessing
A Siemens Trio Tim 3 T scanner with a 12 channel head coil
was used for image acquisition. Functional images were obtained
using a Gradient-echo T2*-weighted echo planar sequence
and consisted in 32 non-contiguous oblique axial planes (in
order to minimize signal drop-out in ventral regions, which
was especially important according to our hypothesis). Other
parameters included relaxation time = 2000ms; echo time =
30ms; ﬂip angle= 78; voxel size= 3.14×3.14×3.75mm3, matrix
size 64 × 64; bandwidth 2232 HZ/Px. The structural image was
obtained using a high-resolution T1-weighted three-dimensional
MP-RAGE sequence.
Imaging preprocessing and analysis was carried out using the
FEAT v5.98 (FMRI Expert Analysis Tool) routine within the FSL
program (FMRIB’s Software Library, www.fmrib.ox.ac.uk/fsl).
Functional time-series were sequentially realigned, coregistered
to a whole brain echo-planar image and ﬁnally to the structural
high resolution T1 image, and non-brain components were
removed. Functional images were also spatially smoothed using a
6mm at full width half-maximum (FWHM) Gaussian kernel and
frequency ﬁltered (130 s cut oﬀ). Images were normalized to the
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FIGURE 1 | Design of the paradigm. There were two conditions, reward (top) and neutral (bottom) that were signaled by an unambiguous cue and were followed by
the subject pressing a button and then by two possible outcomes with different frequencies (0.7 or 0.3 probability of occurrence).
Montreal Neurological Institute (MNI) standard template and
the ﬁrst six volumes were discarded to allow for T1 equilibration
eﬀects.
Statistical Analysis
Non-imaging Data
Non-imaging comparisons were carried out in SPSS 21 (IBM,
Armonk, NW, US). Results were considered signiﬁcant if p <
0.05. Normality of all variables was initially evaluated through
visual inspection of histograms, whisker plots, and Q-Q plots in
the 3 groups.
Results from clinical scales did not follow a normal
distribution in at least one of the groups. Hence, diﬀerences
between groups were tested using Kruskal-Wallis ANOVA. To
investigate diﬀerences in proportions (gender, handedness, and
ethnicity) Chi-square comparisons were carried out. Finally,
variables which a-priori were considered to be more likely to
meet ANOVA assumptions, and for which the results of the
initial inspection was less clear (age, intelligence, and education),
were taken to a One-Way ANOVA, residuals saved, and explored
through inspection of histograms, whisker plots, and Q-Q plots.
In the case of these three variables there was some evidence for
a non-fully normal distribution of the residuals. However, since
ANOVA is considered to be robust to deviations from normality,
parametric results are reported in the main article. Additionally,
results from Kruskal-Wallis ANOVAs for these variables can be
found in Supplementary Material.
Whenever an ANOVA was signiﬁcant, we conducted post-
hoc tests consisting of pair-wise comparisons corrected for
multiple testing. In the case of Kruskal-Wallis ANOVA, adjusted
signiﬁcance levels were calculated by multiplying the unadjusted
signiﬁcance values by the number of comparisons with a
maximum p-value of 1 (SPSS standard method). Gabriel (due to
the slightly unequal sample sizes) or Games-Howell procedures
were used for One-Way ANOVAs depending on the result of
Levene’s test on the inequality of variances; the latter was used
if the test was signiﬁcant.
In the case of response times, whisker plots representing data
in the reward and neutral condition showed that a participant
with depression had a much higher response time in both
conditions. However, the diﬀerence between the RT in both
conditions was within normal parameters (as conﬁrmed by
the evaluation of the residuals of the RT diﬀerences between
conditions), and therefore not likely to inﬂuence the results.
Nevertheless, we carried out a repeated-measures ANOVA
(within subjects eﬀect: Two levels of condition, between subjects
eﬀect: group) with and without this participant.
Imaging Data
We used a single statistical linear regression model with 6
explanatory variables (reward cue, neutral cue; high reward
outcome, low reward outcome, and the two neutral outcomes)
and their temporal derivatives. Movement parameters from the
realignment step were also included in the ﬁrst-level model.
The a-priori contrast of interest was the anticipation of reward
and consisted of the comparison of the BOLD levels during the
reward cue and the neutral cue. The reward anticipation contrast
uses all cue events in the experiment, with 30 neutral cues and 30
reward cues. Other possible contrasts included the comparison
between outcomes, but it was decided not to investigate them
at the group level due the reduced number of events that they
involved, and because well-predicted rewards often evoke limited
brain activity at the time of reward delivery (Berns et al., 2001).
The reward anticipation contrast (reward cue vs. neutral cue)
from the ﬁrst level was taken to the group-level analysis, where
it was included in a one sample analysis (control group only,
to illustrate this contrast in the healthy population), and One-
Way between groups ANOVA (to investigate group diﬀerences).
Diﬀerences were evaluated at the whole brain level and within
an a-priori volume of interest mask of the ventral striatum
previously used by our group (Bernacer et al., 2013). This region
of interest (ROI) included the nucleus accumbens and ventral
aspects of the caudate nucleus and putamen (blue regions in
Figure 4). Comparisons at the whole brain level and within the
ROI were cluster-thresholded using a family-wise error (FWE)
correction of p < 0.05 after a strict initial cluster threshold of
Z > 3 (Woo et al., 2014). Uncorrected results are also displayed
in Supplementary Material as part of exploratory analyses that
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may be of use in future hypothesis generation and meta-analyses,
using the same Z > 3 threshold and a minimum cluster size of
10 across the whole brain.
We extracted the mean parameter estimates for all clusters of
diﬀerential activation between groups in the imaging ANOVA
analysis (using the FSL tool Featquery in the normalized
individual images). Then, post-hoc pairwise comparisons (two-
tailed t-tests, equality of variances was not assumed if Levene’s
test was statistically signiﬁcant), aimed at exploring the group
diﬀerences that were driving the signiﬁcant ANOVA results, were
carried out in SPSS. The same post-hoc analysis procedure was
used for the signiﬁcant clusters within the ROI comparison of the
ventral striatum region.
Activation tables were created using Autoaq (Automatic atlas
queries for fsl: http://brainder.org/2012/07/30/automatic-atlas-
queries-in-fsl). Number of voxels, maximum voxel Z-value (Z
max), MNI coordinates of the maximum peak (MAX X,Y,Z),
anatomical label of themax peak and signiﬁcant pairwise post-hoc
t-test comparisons are reported within tables. Anatomical labels
were the most probable location of the highest peak according
to the Harvard-Oxford cortical and subcortical structural atlases
included in FSL (Desikan et al., 2006). Images were created
using MRIcroN (C. Rorden; http://www.mccauslandcenter.sc.
edu/mricro/mricron/index.html) and presented in neurological
form (right in the image corresponds to the right hemisphere).
A secondary analysis consisted of carrying out Spearman
correlations between the mean parameter estimates in the right
ventral striatum and clinical symptoms in each of the groups
separately. The right ventral striatum was selected as it was
the region with reduced activation in schizophrenia and in
depression.
Results
There were no group diﬀerences in age, gender, handedness,
years of education, or ethnicity. As expected, participants with
schizophrenia had a lower IQ and patients had greater psychiatric
symptomatology than healthy controls (Table 1, Table S1).
Response times were shorter in the reward condition (F =
36.71, p ≤ 0.001) but did not diﬀer between groups (F = 0.384,
p = 0.683). Figure 2 shows whisker plots for the three groups
and the two conditions and Table 2 summarizes means and
standard deviations. This diﬀerence in response time between
conditions is characteristic of the paradigm hence indicating that
the experimental manipulation was eﬀective in the whole group
of participants (Hägele et al., 2015). Results did not change when
a subject with slow RTs was taken out (within subject factor F =
40.348, p ≤ 0.001; between subject factor F = 0.624 p = 0.540).
Reward anticipation (contrast of reward cue vs. neutral cue)
in the control group activated areas in the frontal lobe (medial
frontal cortex, anterior cingulate cortex), striatum, and thalamus,
and cerebellum (FWE cluster corrected across the whole brain
p < 0.05; see Figure 3 and Table S2). When the three groups
were compared using ANOVA, no clusters survived the multiple
comparison correction at the whole brain level. However, the
ROI analysis in the ventral striatum led to the appearance of
two clusters (signiﬁcant when corrected formultiple comparison)
FIGURE 2 | Reaction time. Repeated measures ANOVA (within subject
factor: condition, between subject factor: group): reaction times in reward trials
were shorter (F = 36.71, p = 0.001) but did not differ between groups
(F = 0.384, p = 0.683). For graphical purposes a subject from the depression
group was eliminated from the image due to a much greater mean RT (around
800ms) in both conditions, but included in the statistical analysis (However, its
elimination from the ANOVA did not change significant results). Central line
represents the median value (second quartile, Q2) and the box borders
indicate the 1st (Q1) and 3rd quartile (Q3). Hence, the total length of the box is
the interquartile range (IQR). Whiskers mark last value in the sample located
between the 1.5 × IQR below Q1 and 1.5 × IQR above Q3. Circles represent
data between the 1.5 and 3× IQR below Q1 or above Q3.
TABLE 2 | Response times by group and condition.
C (n = 17)
Mean ± sd
D (n = 20)
Mean ± sd
S (n = 22)
Mean ± sd
p Levene
RT reward 0.321 ± 0.057 0.331 ± 0.135 0.342 ± 0.058 0.322
RT neutral 0.356 ± 0.066 0.367 ± 0.126 0.368 ± 0.068 0.427
C is the control group, D depression and S schizophrenia. p Levene is the p-value of
Levene’s test for the inequality of variances. Standard deviations are denoted as ± sd.
bilaterally in the accumbens nuclei (Figure 4, Table 3). As
ANOVA does not indicate the direction of group diﬀerence
eﬀects, we employed post-hoc tests. Post-hoc analysis showed
activation was signiﬁcantly greater in the controls than the
depressed patients in the right and left accumbens; controls’
activation was signiﬁcantly higher in the right, but not left,
accumbens when compared to schizophrenia patients; the two
patient groups did not diﬀer from each other (Figure 5 and
Table 3).
There were two clusters with Z-values above 3 and a cluster
size greater than 10 in the uncorrected whole-brain analysis
(Table S3). One was located in the right accumbens, the other in
the frontal pole. A cluster of eight voxels in the left accumbens
was the next biggest cluster. The frontal pole result was derived
Frontiers in Psychology | www.frontiersin.org 6 August 2015 | Volume 6 | Article 1280
Arrondo et al. Cross-diagnostic striatal reward anticipation dysfunction
FIGURE 3 | Increased activation during the anticipation of a reward
(reward cue vs. neutral cue) in the healthy controls (1-sample t-test of
the first level contrast between reward and neutral cues). Yellow color
indicates voxels within significant clusters corrected at the whole brain level
(cluster family wise error corrected p < 0.05 after a cluster-inducing primary
threshold of Z > 3). Numbers under slices indicate mm in the MNI coordinate
system. The left side of the image represents the left side of the brain.
from a reduced activation in the depression group compared to
the other two groups.
An analysis of correlations between anhedonia (SHAPS and
TEPS scales), depression (BDI), psychiatric symptoms (BPRS),
and positive and negative symptoms (PANSS and SANS scales)
and the parameter estimates in the right ventral striatal cluster of
signiﬁcant diﬀerences in the ANOVA was carried out (Table 4
and Figures S1–S9 in Supplementary Material). A negative
correlation between severity of depression and anhedonia
symptoms and ventral striatum activity was found in the
schizophrenia group. Regarding anhedonia, SHAPS and the total
TEPS score were statistically signiﬁcant, whereas TEPS’ subscales
showed a trend toward signiﬁcance (marginal signiﬁcance). The
correlation with SANS was also close to signiﬁcance. Signiﬁcant
results found in schizophrenia patients did not hold in the other
FIGURE 4 | Differences between groups in reward anticipation
(One-Way ANOVA of the first level contrast between reward and
neutral cues). Yellow color indicates voxels within significant clusters: cluster
family wise error corrected p < 0.05 within the ventral striatum after a
cluster-inducing primary threshold of Z > 3. The region of interest is shown in
blue on the left of the image. For improved visualization cluster limits are not
circumscribed to our ROI. Differences were driven by greater activations in the
healthy controls group compared to both groups of patients (right ventral
striatum) or only the depression group (left ventral striatum). Numbers under
slices indicate mm in the MNI coordinate system. The left side of the image
represents the left side of the brain.
groups and the direction of other correlations, such as the BPRS
and PANSS negative symptoms within the depression group, was
opposed to that expected.
Discussion
We used a Monetary Incentive Delay (MID) paradigm in a
single experiment designed to examine activation during reward
anticipation in controls, schizophrenia, and depression. Both
clinical groups had a reduction in right ventral striatal activity
when anticipating rewards as predicted; results in the left ventral
striatum were reduced in depression but not deﬁnitively reduced
in schizophrenia. We were not able to ﬁnd a clear correlation
between striatal activation and clinical symptoms of depression
or anhedonia in the depression group, but such a correlation was
present in the schizophrenia group. The design of the study is
consistent with the Research Domain Criteria (RDoC) project:
one of the designs that the RDoC framework has proposed is
to include participants with disorders from diﬀerent sections
of the DSM/ICD diagnostic manuals with the aim of exploring
an abnormal neurobehavioral construct to further understand
its pathological mechanisms (Cuthbert, 2014a). The rationale
underlying the study was the fact that neurocognitive domains
of motivation and reward processing have been proposed to be
abnormal in both disorders, and such abnormalities may be at the
root of the some of the common features between schizophrenia
and depression.
Our results of reduced right ventral striatal activity during
reward anticipation in both depression and schizophrenia can
be considered a replication of the work of Hägele et al.
which was recently published (2015). The combined evidence
of both studies suggests that reduced BOLD signaling in the
right nucleus accumbens is indeed a hallmark of pathological
reward anticipation. The results in the left accumbens are
more equivocal; unlike Hägele and colleagues, we demonstrated
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TABLE 3 | Differences between groups in reward anticipation compared to the anticipation of a neutral outcome (ANOVA F test).
Voxels Z MAX MAX MAX MAX Label Post-hoc pair-wise comparisons
X (mm) Y (mm) Z (mm)
C vs. D C vs. S D vs. S Summary
17 3.92 8 16 −4 Right Accumbens t = 2.51, p = 0.016 t = 2.06, p = 0.046 t = -0.79, p = 0.431 C>D&S
1 3.15 −8 16 −4 Left Accumbens t = 2.96, p = 0.005 t = 1.39, p = 0.171 t = -0.91, p = 0.371 C>D
Corrected clusters (p < 0.05 FWE after a primary cluster inducing threshold of Z > 3 within the ventral striatum) are displayed. Number of voxels, maximum voxel Z-value (Z max), MNI
coordinates of the maximum peak (MAX X,Y,Z), anatomical label of the max peak and post-hoc pair-wise t-tests are reported. C is the control group, D depression, and S schizophrenia.
Any significant post-hoc test results for two-group (pair-wise) comparisons (p < 0.05) are also indicated by the use of “greater than” symbols (eg., S&D>C indicates that results in
pair-wise comparisons S vs. C and D vs. C were significant).
FIGURE 5 | Reward anticipation mean parameter estimates in the
accumbens nucleus: Obtained from the right and left significant
clusters (p < 0.05 FWE cluster corrected after a cluster-inducing
threshold of Z > 3 within a ventral striatum ROI) in the between groups
One-Way ANOVA of the first level contrast comparing reward and
neutral cues. Parameter estimates are arbitrarily scaled values. Central line
represents the median value (second quartile, Q2) and the box borders
indicate the 1st (Q1), and 3rd quartile (Q3). Hence, the total length of the box is
the interquartile range (IQR). Whiskers mark last value in the sample located
between the 1.5 × IQR below Q1 and 1.5 × IQR above Q3. Circles represent
data between the 1.5 and 3× IQR below Q1 or above Q3, whereas asterisks
are data further apart from the median.
reduced left accumbens activation in depression, but similar to
Hägele and colleagues we failed to demonstrate a conclusive
abnormality here in schizophrenia. Further study will be required
to investigate whether there is any fundamental pathological
importance in this small laterality eﬀect or whether it relates to
more trivial issues such as the precise sensitivity of the paradigm.
In the case of schizophrenia, our ﬁndings are not new,
as previous studies had also found decreased activity in the
basal ganglia and speciﬁcally in the ventral striatum (Nielsen
et al., 2012), although other smaller studies did not ﬁnd such
diﬀerences (Walter et al., 2009; Waltz et al., 2010). On the other
hand, results in the MID paradigm with depression patients
have been surprisingly inconclusive. For example, the ﬁrst study
using the MID in depression (n = 14 patients and 12 controls)
showed no evidence of abnormality in the basal ganglia (Knutson
et al., 2008). Our study and the work by Hägele et al. are among
the ones with the biggest sample sizes and when taken into
account in a combined way strongly suggest that abnormalities
in the reward circuit are not limited to patients with a diagnosis
of schizophrenia, but also relate to patients with depression
symptoms. Other data such as a meta-analysis on reward and
depression (Zhang et al., 2013) and a study by Pizzagalli et al.
(2009), indicate that reduced basal ganglia activations may not
only (or even primarily) be located in the ventral striatum, but
could also involve other subcortical regions such as the caudate
head or the posterior putamen. We were not able to conﬁrm the
results of the meta-analysis by Zhang and colleagues suggesting
frontal and anterior cingulate over-activation in depression
during reward anticipation.
One reason that has been put forward to account for the
discrepancies between MID depression studies has been that
reward is usually contingent on a speeded performance on the
MID, which might be inﬂuencing some patients through a stress
related, possibly dopaminergic, response (Treadway and Zald,
2011); these authors argue that the necessity to respond rapidly
may enhance activation particularly in anxious patients, whose
motivation may relate to hypersensitivity to perceived failure.
To deal with this potential confound we modiﬁed the original
task so reward did not depend on the speed of the response.
This change may be related to the ﬁnding of reduced accumbens
activation, which has also been shown in other experiments in
which a speeded motor response was not involved (Smoski et al.,
2009). It must be noted however that the paradigm used in
the studies reported by Hägele et al. (2015) was closer to the
original design of the MID and included the necessity of a fast
response to obtain the reward. Similarly, we did not include a
loss condition in our design, as it has been proposed that the
strongest activations in healthy controls and when comparing
them to patients come from contrasting the gain and neutral
cues (Hägele et al., 2015) Hence, our design may be suitable
and sensitive for psychiatric research when the main objective
is to study reward processing. Although reward was delivered
irrespective of the speed of button pressing, response time in
the reward condition was shorter. Valence eﬀects on response
time can occur irrespective of a direct consequence of speeded
responses (O’doherty et al., 2004; Pessiglione et al., 2006; Murray
et al., 2008b). The phenomenon has been termed “reinforcement
related speeding” (Cools et al., 2005; Murray et al., 2008a), and it
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TABLE 4 | Correlation between symptoms and parameter estimates in the right nucleus accumbens.
C D S
R p R p R p
BPRS 0.110 0.664 0.584 0.003 −0.045 0.842
BDI −0.030 0.898 0.285 0.176 −0.457 0.033
SHAPS −0.405 0.069 0.163 0.447 −0.483 0.023
TEPS ant 0.237 0314 −0.332 0.113 0.389 0.073
TEPS con −0.074 0.757 −0.220 0.302 0.396 0.068
TEPS total 0.103 0.665 −0.367 0.078 0.432 0.045
PANSS + 0.111 0.633 0.304 0.149 −0.046 0.840
PANSS − 0.000 1.000 0.471 0.020 −0.300 0.174
SANS – – 0.227 0.286 −0.401 0.065
C is the control group, D depression, and S schizophrenia. Parameter estimates correspond to the mean of the parameter estimates in the clusters of differential activation between
groups in the accumbens (obtained from the right significant cluster in the ANOVA comparing reward anticipation activity between groups). R is the Spearman correlation between the
measures. BPRS is Brief Psychiatric Rating Scale, BDI is Beck Depression Inventory, TEPS is the Temporal Experience of Pleasure Scale (ant, anticipatory subscale; con, consummatory
subscale), SHAPS is Snaith–Hamilton Pleasure Scale, PANSS is Positive and Negative Syndrome Scale (+, positive symptoms; −, negative symtoms), and SANS is Scale for the
Assessment of Negative Symptoms.
is thought that a potential reward leads to enhanced motivation
and hence faster responding (Crespi, 1942).
Whilst the right accumbens was a site of common
underactivation in both patient groups compared to controls,
no diﬀerences between the two patient groups were found. This
result indicates that the two groups of psychiatric participants
may be more similar to each other than when compared to
healthy controls, which would be in accordance with the RDoC
perspective of a common abnormal domain. Comparisons
between patient groups were not reported in Hägele et al.,
but a qualitative analysis of their plotted results show them
to be in line with ours; the two patient groups had a similar
activity reduction in the striatum. Regarding the eﬀects of
the medications for psychosis, it is a limitation that all of the
schizophrenia patients were taking antipsychotic medication.
Thus, we cannot exclude the possibility that the results may
in part be secondary to medication eﬀects. However, we note
that as a previous study from the Berlin group found that
the striatal deactivation normalized when changing from
typical to atypical antipsychotics (Schlagenhauf et al., 2008),
and as all of our schizophrenia patients were taking atypical
antipsychotic medication, it is unlikely that the results are
solely due to medication. Nevertheless, it will be important,
albeit challenging, to study medication free samples in future
research.
The second hypothesis was that the BOLD signal in the
striatum would negatively correlate with clinical symptoms of
depression and anhedonia. Previous studies have only reported
one or two clinical measures per study, but clinical constructs
that correlated with the activity of the ventral striatum have
included depression (Hägele et al., 2015) anhedonia and apathy
(Simon et al., 2010; Stoy et al., 2012), positive symptoms (Nielsen
et al., 2012) or negative (Juckel et al., 2006a; Waltz et al.,
2009) symptoms, and severity of overall psychiatric symptoms
measured by the BPRS (Waltz et al., 2009). In accordance
with our cross-diagnostic approach and the aim of further
investigating the mechanisms of abnormal reward processing,
we decided to include a broad range of clinical measures
that encompassed most of the constructs previously reported
to correlate with striatal activity in the MID. Results in this
regard were mixed. On the one hand we were able to replicate
Hägele’s et al. results of reduced activity in the right accumbens
nucleus of those schizophrenia participants with more depressive
symptoms. We also extend the results of Hägele and colleagues
to relationships between less activity and more anhedonia in
schizophrenia, as measured by the TEPS and SHAPS scales.
A limitation of our work is that we did not correct our
correlation analyses for multiple comparisons, and considering
the modest eﬀect sizes observed, those signiﬁcant correlations
we do ﬁnd may be vulnerable to Type I error. In contrast to
results from Hägele et al., neither the BDI nor any of the other
measures were associated with ventral striatal activation in both
patient groups. However, the lack of brain-symptom associations
demonstrated in the depression group, and the control group
(as some of the scales were designed to assess patients only),
cannot be considered as evidence of absence of brain-symptom
relations. Some correlations such as the signiﬁcant positive
relationship between activation and the BPRS and PANSS
(negative symptoms subscale) scales in the depression group
were counterintuitive (and not maintained across groups).
This may reﬂect a chance ﬁnding, or, as Treadway and Zald
(2011) have speculated, the activation elicited by the MID
task may be a composite of activation associated with reward
anticipation and anticipatory anxiety about potential failure. We
attempted to address this possibility by our modiﬁcation of
the task to dissociate reinforcement from performance but it
remains possible that, especially in depression, some symptoms
may relate to striatal overactivity (leading to greater activation
when more psychopathology) and other symptoms may relate
to underactivity. The relationship between psychopathology
and striatal reward processing activation may be complex,
and it is possible that striatal (dys)function may contribute
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to symptom expression only through interactions with other
regional dysfunction and other psychological processes. The
concept of dysfunction of one psychological process in one
brain area leading to expression of one symptom has the
attraction of being a testable hypothesis but is necessarily an
oversimpliﬁcation.
An important challenge in assessing brain-symptom
relationships is accurate symptom measurement. This is
especially challenging when experts disagree about what
constitutes a particular symptom. Anhedonia is deﬁned in
the DSM-IV-TR as a loss of interest or pleasure (American
Psychiatric Association, 2000), which arguably reﬂects the
consensus use of the term over the past 100 or so years (e.g.,
Myerson, 1922; see also Berrios, 1996). However, the DSM-
5 contains a new deﬁnition within the schizophrenia (not
depression) chapter, “the decreased ability to experience pleasure
from positive stimuli or a degradation in the recollection of
pleasure previously experienced,” and arguments continue
as to whether a broad or narrow use of the term is more
helpful (recently discussed by Treadway and Zald, 2011; Der-
Avakian and Markou, 2012; Romer Thomsen et al., 2015).
Consensus appears to be building that in depression and
schizophrenia, anticipatory, and motivational aspects of reward
are more compromised than consummatory (reward receipt)
aspects, possibly related to dopaminergic abnormalities in both
conditions (Argyropoulos and Nutt, 2013; Kring and Barch,
2014; Whitton et al., 2015); though see a recent study (Gard
et al., 2014) documenting enhanced anticipation of pleasure in
schizophrenia). However, it remains possible that this relative
consensus may in part reﬂect the methods that have been
recently used to investigate the issue. Variants of the monetary
incentive delay task as we used here may be more sensitive
to reward anticipation eﬀects than reward delivery eﬀects, as
well-predicted rewards tend to evoke less strong brain responses
than surprising rewards (e.g., Berns et al., 2001). In addition,
given the limited temporal resolution of fMRI it can be hard to
dissociate anticipatory and consummatory aspects of reward.
Furthermore, most fMRI patient studies have, as we did, used
monetary rewards, but processing of primary and secondary
rewards may diﬀer in important respects (Sescousse et al.,
2013).
Strengths and Limitations
As noted, our work is similar to existing research, such as
that of Hägele and colleagues. However, there are diﬀerences
between the two studies. Our study was at higher ﬁeld strength
(we used a 3 Tesla magnet vs. a 1.5 Tesla of Hägele and all).
Our study uses a matched control group whereas Hägele and
colleagues, because theirs is a retrospective synthesis and re-
analysis of previously published separate works, use a control
group that is not matched to their patients in the basic features
of age and gender. Our study uses diﬀerent (slightly simpler)
stimuli to Hägele and colleagues and, while both studies require
a button press, in ours, the reinforcement is not actually
contingent on the button press reaction time (as discussed
above, this was suggested by Treadway and Zald (2011) as
being advantageous in reducing anticipatory anxiety). Our study
includes a more detailed assessment of psychopathology (with
the limitations that, as previously mentioned, when utilizing the
psychopathology for correlation analyses we did not correct for
multiple correlations, and that our sample size is modest for
correlation analysis).
Conclusion
In summary, while a reduced activation in the ventral striatum
when anticipating rewards is a common endophenotype in
psychopathology, the mechanisms underpinning this ﬁnding and
related symptoms are not completely clear. It will be crucial
to further pinpoint the clinical relevance of this ﬁnding but
it will require further studies and replications. Although some
evidence from both the previous literature and our work points
toward negative or depressive symptoms being more related
to the reported ﬁnding, they require further conﬁrmation. The
future of this line of research ﬁts nicely within the speciﬁcations
laid out by the RDoC project, although it also faces similar
challenges, such as the measurement error, and the biological
and psychometric limitations of proposed endophenotypes and
their relationship to behavior (Cuthbert, 2014b; Lilienfeld, 2014;
Weinberger and Goldberg, 2014). Upcoming studies on reward
and psychopathology will have to use bigger sample sizes
and a broader range of clinical measurements in order to
be able to obtain a compelling evidence of the relationship
between brain activation and everyday behavior. As shown
in our work, future studies could beneﬁt from including
participants with a range of diagnoses. This aim can be
best achieved by a large-scale collaboration across diﬀerent
research groups. Moreover, the wide use of the MID task
makes it a good candidate measure for such collaboration,
although a common “oﬃcial” version would be important. Our
results indicate that a paradigm that does not base reward on
performance might be better ﬁtted for research with stress-prone
participants.
Our overall ﬁndings are further evidence of reward system
dysfunction across the neuropsychiatric continuum, even if the
speciﬁc clinical relevance is still not fully understood. Studies on
this line of fruitful research could provide new insights on the
cross-diagnostic mechanisms of psychopathological symptoms,
especially if conducted in a way that minimizes the challenges
posed to the Research Domain Criteria approach.
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